Biologic drugs comprise 40 percent of the current drug development pipeline. Existing in vitro and animal models are limited in their ability to evaluate the safety and efficacy of these drugs in humans. These limitations often result in development delays and increased costs.
Organs-on-chips emulate human biology by providing a micro-engineered environment lined with living human cells and tissues. Each chip recreates the natural physiology and mechanical forces that cells experience within the human body.
This digital event brings together the world’s leading experts for an extensive exploration of how organs-on-chips provide a far more predictive model of human biology. Together, we’ll discover the latest developments of how this advanced technology is transforming therapeutic research. We’ll also feature informative breakout sessions on neurology, inflammation, infectious diseases, and the future of organs-on-chips.
Join us as we open new windows into human biology. Attend the event on alternative in vitro tools.
Emulate Inc. is a privately held company that creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health. Our lab-ready Human Emulation System® includes three components: Zoë® Culture Module, Organ-Chips, and analytical software applications. The platform provides a window into the inner workings of human biology and disease—offering researchers a new technology designed to predict human response with greater precision and detail than conventional cell culture or animal-based experimental testing. Each of the Emulate proprietary Organ-Chip models—including the liver, intestine, and kidney—contains tiny hollow channels lined with tens of thousands of living human cells and tissues and is approximately the size of an AA battery. An Organ-Chip is a living, microengineered environment that recreates the natural physiology and mechanical forces that cells experience within the human body. Our founding team pioneered the Organs-on-Chips technology at the Wyss Institute for Biologically Inspired Engineering at Harvard University. Emulate holds the worldwide exclusive license from Harvard University to a robust and broad intellectual property portfolio for the Organs-on-Chips technology and related systems. For more information, please visit emulatebio.com.